MONDAY, Aug. 12, 2024 -- For patients with cervical radiculopathy, posterior surgery is noninferior to anterior surgery with respect to success rate...
Vous n'êtes pas connecté
MONDAY, July 8, 2024 -- Second- or third-line treatment with tisotumab vedotin is efficacious for patients with recurrent cervical cancer, according to a study published in the July 4 issue of the New England Journal of Medicine. Ignace Vergote...
MONDAY, Aug. 12, 2024 -- For patients with cervical radiculopathy, posterior surgery is noninferior to anterior surgery with respect to success rate...
MONDAY, Aug. 19, 2024 -- Patients with rare cancers have poor psychological outcomes, according to a review and meta-analysis published in the June...
Patients with liver cancer who received immune checkpoint inhibitors (ICIs) before surgery – including those who would not have been eligible for...
An iron-binding drug that is already approved for treatment of other diseases could provide a novel way to attack ovarian tumours, according to a new...
TUESDAY, Aug. 13, 2024 -- For patients with atrial fibrillation (AF), wearable devices are associated with higher AF-specific health care use and...
MONDAY, Aug. 19, 2024 -- The geographic distance to facilities offering breast magnetic resonance imaging (MRI) or ultrasound is further than to...
FRIDAY, Aug. 16, 2024 -- For patients with hepatocellular carcinoma (HCC), immune checkpoint inhibitor (ICI) use prior to liver transplant (LT) does...
FRIDAY, Aug. 16, 2024 -- Cognitive motor dissociation is seen in about 25 percent of individuals with disorders of consciousness without an observable...
TUESDAY, Aug. 20, 2024 -- Spouses of patients with cancer have an increased risk for suicide attempt and suicide death, especially during the first...
FRIDAY, Aug. 16, 2024 -- Patients with skin of color may experience more adverse events from sclerotherapy, according to a study published online...